Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Public ClinicalTrials.gov record NCT04306939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, descriptive, observational research study designed to observe and document the clinical practice by domain experts, and how the knowledge of new findings that are published in the medical literature affect clinical decision making. The study will evaluate risk factors and co-variants, including genetic variants that are associated with disease progression such as pain, inflammation, organ dysfunction, disability and quality of life.
Study identification
- NCT ID
- NCT04306939
- Recruitment status
- Suspended
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 120,000 participants
Conditions and interventions
Conditions
- Chronic Pancreatitis
- Inflammatory Bowel Diseases
- Hepatitis
- NASH - Nonalcoholic Steatohepatitis
- Acute Pancreatitis
- Rheumatoid Arthritis
- Diabetes Mellitus
- Dyslipidemias
- Multiple Sclerosis
- Irritable Bowel Syndrome
- Chronic Pain
- Chronic Disease
- Chronic Kidney Diseases
- Crohn Disease
- Celiac Disease
- Biliary Cirrhosis
- Bile Acid Synthesis Defect
- Gastritis
- Cholecystitis
- Cholelithiases
- IPMN
- Cyst Pancreas
- Cystic Fibrosis
- Pancreatic Exocrine Insufficiency
- Diarrhea Chronic
- Constipation - Functional
- Constipation Chronic Idiopathic
Interventions
- venipuncture Other
- Questionnaires Behavioral
- Additional Sample Collections Other
Other · Behavioral
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2014
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Jan 6, 2026
2014 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04306939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04306939 live on ClinicalTrials.gov.